PTGX

Protagonist Therapeutics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Protagonist Therapeutics Inc PTGX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-1.20 -6.86% 16.29 16.14 17.60 17.44 17.49 00:00:02
more quote information »

Recent News

Date Time Source Heading
6/17/202023:07PRNUSHepcidin Mimetic PTG-300 Receives U.S. FDA Orphan Drug..
6/16/202018:05PRNUSProtagonist Therapeutics to Participate in the BMO..
6/09/202016:33EDGARAmended Statement of Ownership (sc 13g/a)
6/08/202016:05EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
6/04/202007:00PRNUSProtagonist Therapeutics to Present at the 25th European..
5/29/202018:21EDGARStatement of Changes in Beneficial Ownership (4)
5/29/202018:20EDGARStatement of Changes in Beneficial Ownership (4)
5/29/202018:19EDGARStatement of Changes in Beneficial Ownership (4)
5/29/202018:17EDGARStatement of Changes in Beneficial Ownership (4)
5/29/202018:16EDGARStatement of Changes in Beneficial Ownership (4)
5/29/202018:13EDGARStatement of Changes in Beneficial Ownership (4)
5/29/202016:06EDGARCurrent Report Filing (8-k)
5/28/202007:00PRNUSProtagonist Therapeutics to Present at Two Upcoming..
5/22/202016:31EDGARStatement of Ownership (sc 13g)
5/13/202006:05EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/12/202010:54EDGARCurrent Report Filing (8-k)
5/12/202000:57PRNUSProtagonist Therapeutics, Inc. Announces Upsizing and..
5/11/202007:00EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/11/202006:59PRNUSProtagonist Therapeutics, Inc. Announces Proposed..
5/07/202017:17EDGARQuarterly Report (10-q)
5/07/202016:42EDGARCurrent Report Filing (8-k)
5/07/202016:31PRNUSProtagonist Therapeutics Reports First Quarter Financial..
5/07/202016:30PRNUSProtagonist Therapeutics Announces Initial Phase 2 Results..
5/04/202007:00PRNUSProtagonist Therapeutics to Announce First Quarter 2020..
5/01/202017:33EDGARStatement of Changes in Beneficial Ownership (4)
4/16/202017:30EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/16/202017:29EDGARProxy Statement (definitive) (def 14a)
4/15/202020:35PRNUSProtagonist Therapeutics Reports Granting of Inducement..
4/08/202017:47EDGARStatement of Changes in Beneficial Ownership (4)
3/23/202018:15EDGARStatement of Changes in Beneficial Ownership (4)
3/18/202016:43EDGARCurrent Report Filing (8-k)
3/13/202013:05EDGARStatement of Changes in Beneficial Ownership (4)
3/12/202019:27EDGARStatement of Changes in Beneficial Ownership (4)
3/10/202017:25EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/10/202017:19EDGARAnnual Report (10-k)
3/10/202016:06EDGARCurrent Report Filing (8-k)
3/10/202016:01PRNUSProtagonist Therapeutics Reports Fourth Quarter and Full..
3/02/202016:30PRNUSProtagonist Therapeutics to Announce Fourth Quarter and Full..
2/28/202018:16EDGARStatement of Changes in Beneficial Ownership (4)
2/28/202018:16EDGARStatement of Changes in Beneficial Ownership (4)
2/28/202018:16EDGARStatement of Changes in Beneficial Ownership (4)
2/28/202018:16EDGARStatement of Changes in Beneficial Ownership (4)
2/28/202018:15EDGARStatement of Changes in Beneficial Ownership (4)
2/24/202016:06EDGARCurrent Report Filing (8-k)
2/19/202007:00PRNUSProtagonist Therapeutics to Present at the SVB Leerink 9th..
2/14/202016:22EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202016:05EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202014:40EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202013:27EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202006:20EDGARAmended Statement of Ownership (sc 13g/a)
See more news about this stock »
Your Recent History
NASDAQ
PTGX
Protagonis..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200712 00:23:59